|
Volumn 2, Issue 2, 2011, Pages 101-103
|
Effects of medical therapies on retinopathy progression in type 2 diabetes: Is blood pressure control the lower the better?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
FENOFIBRATE;
GLICLAZIDE;
HEMOGLOBIN A1C;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INDAPAMIDE;
INDAPAMIDE PLUS PERINDOPRIL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NISOLDIPINE;
PERINDOPRIL;
PLACEBO;
PRORENIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
ANTIHYPERTENSIVE ACTIVITY;
BLOOD PRESSURE REGULATION;
CLINICAL ASSESSMENT TOOL;
DIABETIC RETINOPATHY;
DISEASE SEVERITY;
DYSLIPIDEMIA;
EARLY TREATMENT DIABETIC RETINOPATHY STUDY SEVERITY SCALE;
GLYCEMIC CONTROL;
HUMAN;
HYPERTENSION;
LASER COAGULATION;
LIPID BLOOD LEVEL;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RATING SCALE;
RISK REDUCTION;
VITRECTOMY;
|
EID: 79961085029
PISSN: 20401116
EISSN: 20401124
Source Type: Journal
DOI: 10.1111/j.2040-1124.2010.00085.x Document Type: Note |
Times cited : (4)
|
References (5)
|